95041-90-0
95041-90-0
Chemical Structure
Erianin
- CAS No.: 95041-90-0
- Formula:C18H22O5
- Molecular Weight:318.36
IUPAC Name: 2-methoxy-5-(3,4,5-trimethoxyphenethyl)phenol
InChIKey: UXDFUVFNIAJEGM-UHFFFAOYSA-N
SMILES: OC1=CC(CCC2=CC(OC)=C(OC)C(OC)=C2)=CC=C1OC
Biological Activity: Erianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Erianin | 99.60% | Erianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Erianin (Standard) | ≥98% | Erianin (Standard) is the analytical standard of Erianin. This product is intended for research and analytical applications. Erianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Chrysotobibenzyl | Chrysotobibenzyl can be isolated from stem of Dendrobium pulchellum. Chrysotobibenzyl inhibits lung cancer cell (H460 and H292) migration, invasion, filopodia formation via Cav-1, integrins β1, β3, and αν, and EMT suppressions. Chrysotobibenzyl also sensitizes lung cancer cell death mediated by Cisplatin (HY-17394). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Chrysotoxine | 99.52% | Chrysotoxine is a dual inhibitor of Src/Akt. Chrysotoxine suppresses cancer stem cells (CSCs) phenotypes by down-regulating Src/Akt signaling. Chrysotoxine reduces cell viability and increases apoptosis level in H460 and H23 cells instead of non-tumor cell lines. Chrysotoxine shows rapid excretion and low bioavailability in rats. Chrysotoxine is used in cancer research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
isoCA-4 | isoCA-4, a Combretastatin A4 derivative, is a tubulin polymerization inhibitor. isoCA-4 has anti-proliferative activities. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Batatasin V | 99.79% | Batatasin V is a natural product that could be isolated from dormant bulbils of Chinese yam (Dioscorea batatus). Batatasin V has the effect of inhibiting plant growth. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5,4'-Dihydroxy-3,4,3'-trimethoxybibenzyl | 5,4'-Dihydroxy-3,4,3'-trimethoxybibenzyl (compound 8) can be isolated from Dendrobium infundibulum (D. infundibulum). 5,4'-Dihydroxy-3,4,3'-trimethoxybibenzyl has no inhibitory activity against α-glucosidase and pancreatic lipase. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Crepidatin | Crepidatin is a bibenzyl compound that can be isolated from the stems of Dendrobium loddigesii. Crepidatin promotes anoikis of lung cancer cells. Crepidatin inhibits the anchorage-independent growth of human lung cancer cells. Crepidatin can be used in lung cancer-related research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3'-Hydroxy-3,4,5'-trimethoxybibenzyl | 3'-Hydroxy-3,4,5'-trimethoxybibenzyl (Compound 5) is a bibenzyl compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Combretastatin A4 (Standard) | ≥98% | Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Gigantol isomer-1 | 99.82% | Gigantol isomer-1 is a bibenzyl compound derived from Dendrobium nobile. Gigantol isomer-1 shows promising therapeutic potential against cancer cells. Gigantol isomer-1 is a novel inhibitor of the Wnt/β-catenin pathway. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dendrophenol | 99.93% | Dendrophenol (Moscatilin) is a NF-κB inhibitor that inhibits inflammation. Dendrophenol exerts potent cytotoxic effect against tumor cells and induces cell cycle arrest and apoptosis. Dendrophenol has antitumor activity. In addition, Dendrophenol can inhibit vascular calcification by inhibiting the activation of WNT3/β-catenin. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
